Risk factors of mortality in severe cutaneous adverse reactions patients with pulmonary involvement

被引：0
|
作者：
H Hu
K Kao
C Huang
C Yang
C Hung
机构：
[1] Chang Gung Memorial Hospital,
来源：
Critical Care | / 16卷 / Suppl 1期
关键词：
Chronic Kidney Disease; Respiratory Failure; Pulmonary Edema; Hospital Mortality; Eosinophilia;
D O I：
10.1186/cc10726
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions
    Wang, Chuang-Wei
    Dao, Ro-Lan
    Chung, Wen-Hung
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 16 (04) : 339 - 345
  • [2] Bronchopulmonary involvement in severe cutaneous adverse reactions
    de Prost, N.
    Mekontso-Dessap, A.
    Valeyrie-Allanore, L.
    Maitre, B.
    REANIMATION, 2013, 22 (01): : 73 - 79
  • [3] Key factors predicting the in-hospital mortality of patients with severe cutaneous adverse reactions in Thailand
    Chuenboonngarm, Nunthanach
    Puaratanaarunkon, Thanaporn
    Washrawirul, Chanudda
    Triwatcharikorn, Jidapa
    Chancheewa, Bussabong
    Theerawattanawit, Chinathip
    Chongpison, Yuda
    Rerknimitr, Pawinee
    Klaewsongkram, Jettanong
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, : 1881 - 1890
  • [4] Risk factors and mortality among patients with severe muco-cutaneous drug reactions
    Cruger, Anne-Mette Torp
    Kaur-Knudsen, Diljit
    Zachariae, Claus
    Rasmussen, Henrik Berg
    Thomsen, Simon Francis
    DANISH MEDICAL JOURNAL, 2015, 62 (08):
  • [5] Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management
    S. Shahzad Mustafa
    David Ostrov
    Daniel Yerly
    Current Allergy and Asthma Reports, 2018, 18
  • [6] Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management
    Mustafa, S. Shahzad
    Ostrov, David
    Yerly, Daniel
    CURRENT ALLERGY AND ASTHMA REPORTS, 2018, 18 (04)
  • [7] Atezolizumab: risk of severe cutaneous adverse reactions
    Reactions Weekly, 2021, 1862 (1) : 1 - 1
  • [8] Recurrence and Mortality Following Severe Cutaneous Adverse Reactions
    Finkelstein, Yaron
    Macdonald, Erin M.
    Li, Ping
    Hutson, Janine R.
    Juurlink, David N.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (21): : 2231 - 2232
  • [9] Mortality and long-lasting sequelae in patients with severe cutaneous adverse reactions
    Mockenhaupt, M.
    Sekula, P.
    Roujeau, J. C.
    Sidoroff, A.
    Kardaun, S.
    Liss, Y.
    Bounoua, M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S115 - S116
  • [10] Risk factors for sulfamethoxazole/trimethoprim-induced severe cutaneous adverse reactions
    Pinyopornpanish, Kanokkarn
    Chungcharoenpanich, Apinya
    Teepapan, Putthapon
    Thadanipon, Kunlawat
    Ruangwattanachok, Chulapha
    Lamrahong, Pansa
    Thongdee, Nattakirana
    Dechapaphapitak, Nizchapa
    Sukasem, Chonlaphat
    Pongphaew, Chanamon
    Jantararoungtong, Thawinee
    Koomdee, Napatrupron
    Laisuan, Wannada
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (05): : 366 - 368
12345